Hepatic encephalopathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Aditya Ganti (talk | contribs) |
||
| (9 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hepatic encephalopathy}} | {{Hepatic encephalopathy}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{MMJ}} | ||
==Overview== | ==Overview== | ||
The [[prevalence]] of subclinical hepatic encephalopathy estimated to be 62,000 cases per 100,000 in patients with hepatic [[cirrhosis]]. The survival probability of hepatic encephalopathy is approximately 42% at 1 year and 23% at 3 years in follow-up. [[Chronic liver disease]] and cirrhosis which are the main causes of hepatic encephalopathy, affect more than 5.5 million people in the United States and hundreds of millions all over the world. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of hepatic encephalopathy is unknown. | *The [[incidence]] of hepatic encephalopathy is unknown. | ||
*The prevalence of subclinical hepatic encephalopathy estimated to be 62,000 cases per 100,000 in | *The [[prevalence]] of subclinical hepatic encephalopathy estimated to be 62,000 cases per 100,000 in patients with hepatic [[cirrhosis]].<ref name="pmid11350549">{{cite journal| author=Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR| title=Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. | journal=J Gastroenterol Hepatol | year= 2001 | volume= 16 | issue= 5 | pages= 531-5 | pmid=11350549 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11350549 }} </ref> | ||
===Prevalence=== | |||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
The survival probability of hepatic encephalopathy is approximately 42% at 1 year and 23% at 3 years in follow-up.<ref name="pmid10365817">{{cite journal| author=Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V et al.| title=Prognostic significance of hepatic encephalopathy in patients with cirrhosis. | journal=J Hepatol | year= 1999 | volume= 30 | issue= 5 | pages= 890-5 | pmid=10365817 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10365817 }} </ref> | |||
===Age=== | ===Age=== | ||
*The incidence of hepatic encephalopathy increases with aging. | |||
*The incidence of | |||
===Gender=== | ===Gender=== | ||
* | *Men are more commonly affected by hepatic encephalopathy than women. | ||
===Region=== | ===Region=== | ||
[[Chronic liver disease]] and cirrhosis which are the main causes of hepatic encephalopathy, affect more than 5.5 million people in the United States and hundreds of millions all over the world.<ref name="pmid23006457">{{cite journal| author=Bleibel W, Al-Osaimi AM| title=Hepatic encephalopathy. | journal=Saudi J Gastroenterol | year= 2012 | volume= 18 | issue= 5 | pages= 301-9 | pmid=23006457 | doi=10.4103/1319-3767.101123 | pmc=3500018 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23006457 }} </ref> | |||
=== | |||
=== | |||
==References== | ==References== | ||
Latest revision as of 05:17, 6 July 2020
|
Hepatic encephalopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hepatic encephalopathy epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hepatic encephalopathy epidemiology and demographics |
|
Hepatic encephalopathy epidemiology and demographics in the news |
|
Blogs on Hepatic encephalopathy epidemiology and demographics |
|
Risk calculators and risk factors for Hepatic encephalopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
The prevalence of subclinical hepatic encephalopathy estimated to be 62,000 cases per 100,000 in patients with hepatic cirrhosis. The survival probability of hepatic encephalopathy is approximately 42% at 1 year and 23% at 3 years in follow-up. Chronic liver disease and cirrhosis which are the main causes of hepatic encephalopathy, affect more than 5.5 million people in the United States and hundreds of millions all over the world.
Epidemiology and Demographics
Incidence
- The incidence of hepatic encephalopathy is unknown.
- The prevalence of subclinical hepatic encephalopathy estimated to be 62,000 cases per 100,000 in patients with hepatic cirrhosis.[1]
Case-fatality rate/Mortality rate
The survival probability of hepatic encephalopathy is approximately 42% at 1 year and 23% at 3 years in follow-up.[2]
Age
- The incidence of hepatic encephalopathy increases with aging.
Gender
- Men are more commonly affected by hepatic encephalopathy than women.
Region
Chronic liver disease and cirrhosis which are the main causes of hepatic encephalopathy, affect more than 5.5 million people in the United States and hundreds of millions all over the world.[3]
References
- ↑ Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR (2001). "Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis". J Gastroenterol Hepatol. 16 (5): 531–5. PMID 11350549.
- ↑ Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V; et al. (1999). "Prognostic significance of hepatic encephalopathy in patients with cirrhosis". J Hepatol. 30 (5): 890–5. PMID 10365817.
- ↑ Bleibel W, Al-Osaimi AM (2012). "Hepatic encephalopathy". Saudi J Gastroenterol. 18 (5): 301–9. doi:10.4103/1319-3767.101123. PMC 3500018. PMID 23006457.